These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

846 related articles for article (PubMed ID: 31220868)

  • 1. Beyond the biopsy: predictors of decision regret and anxiety following preimplantation genetic testing for aneuploidy.
    Goldman KN; Blakemore J; Kramer Y; McCulloh DH; Lawson A; Grifo JA
    Hum Reprod; 2019 Jul; 34(7):1260-1269. PubMed ID: 31220868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perceptions, motivations and decision regret surrounding preimplantation genetic testing for aneuploidy.
    Kaing A; Rosen MP; Quinn MM
    Hum Reprod; 2020 Sep; 35(9):2047-2057. PubMed ID: 32756971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. To test or not to test? A framework for counselling patients on preimplantation genetic testing for aneuploidy (PGT-A).
    Murphy LA; Seidler EA; Vaughan DA; Resetkova N; Penzias AS; Toth TL; Thornton KL; Sakkas D
    Hum Reprod; 2019 Feb; 34(2):268-275. PubMed ID: 30500907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leave the past behind: women's reproductive history shows no association with blastocysts' euploidy and limited association with live birth rates after euploid embryo transfers.
    Cimadomo D; Capalbo A; Dovere L; Tacconi L; Soscia D; Giancani A; Scepi E; Maggiulli R; Vaiarelli A; Rienzi L; Ubaldi FM
    Hum Reprod; 2021 Mar; 36(4):929-940. PubMed ID: 33608730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of pregnancy outcomes following preimplantation genetic testing for aneuploidy using a matched propensity score design.
    Haviland MJ; Murphy LA; Modest AM; Fox MP; Wise LA; Nillni YI; Sakkas D; Hacker MR
    Hum Reprod; 2020 Oct; 35(10):2356-2364. PubMed ID: 32856053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an artificial intelligence model for predicting the likelihood of human embryo euploidy based on blastocyst images from multiple imaging systems during IVF.
    Diakiw SM; Hall JMM; VerMilyea MD; Amin J; Aizpurua J; Giardini L; Briones YG; Lim AYX; Dakka MA; Nguyen TV; Perugini D; Perugini M
    Hum Reprod; 2022 Jul; 37(8):1746-1759. PubMed ID: 35674312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the reproductive potential of day 7 euploid embryos?
    Hernandez-Nieto C; Lee JA; Slifkin R; Sandler B; Copperman AB; Flisser E
    Hum Reprod; 2019 Sep; 34(9):1697-1706. PubMed ID: 31398251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial.
    Verpoest W; Staessen C; Bossuyt PM; Goossens V; Altarescu G; Bonduelle M; Devesa M; Eldar-Geva T; Gianaroli L; Griesinger G; Kakourou G; Kokkali G; Liebenthron J; Magli MC; Parriego M; Schmutzler AG; Tobler M; van der Ven K; Geraedts J; Sermon K
    Hum Reprod; 2018 Sep; 33(9):1767-1776. PubMed ID: 30085138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implicit bias in diagnosing mosaicism amongst preimplantation genetic testing providers: results from a multicenter study of 36 395 blastocysts.
    Popovic M; Borot L; Lorenzon AR; Lopes ALRC; Sakkas D; Lledó B; Morales R; Ortiz JA; Polyzos NP; Parriego M; Azpiroz F; Galain M; Pujol A; Menten B; Dhaenens L; Vanden Meerschaut F; Stoop D; Rodriguez M; de la Blanca EP; Rodríguez A; Vassena R
    Hum Reprod; 2024 Jan; 39(1):258-274. PubMed ID: 37873575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy outcomes following in vitro fertilization frozen embryo transfer (IVF-FET) with or without preimplantation genetic testing for aneuploidy (PGT-A) in women with recurrent pregnancy loss (RPL): a SART-CORS study.
    Bhatt SJ; Marchetto NM; Roy J; Morelli SS; McGovern PG
    Hum Reprod; 2021 Jul; 36(8):2339-2344. PubMed ID: 34027546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preimplantation genetic testing is not a preferred recommendation for patients with X chromosome abnormalities.
    Li C; Dang Y; Li J; Li H; Zhu Y; Qin Y
    Hum Reprod; 2021 Aug; 36(9):2612-2621. PubMed ID: 34323971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individualised luteal phase support in artificially prepared frozen embryo transfer cycles based on serum progesterone levels: a prospective cohort study.
    Álvarez M; Gaggiotti-Marre S; Martínez F; Coll L; García S; González-Foruria I; Rodríguez I; Parriego M; Polyzos NP; Coroleu B
    Hum Reprod; 2021 May; 36(6):1552-1560. PubMed ID: 33686413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follicle size indicates oocyte maturity and blastocyst formation but not blastocyst euploidy following controlled ovarian hyperstimulation of oocyte donors.
    McCulloh DH; Kutchukhidze N; Charkviani T; Zhorzholadze T; Barbakadze T; Munné S; Chkonia L
    Hum Reprod; 2020 Mar; 35(3):545-556. PubMed ID: 32142586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Worth the wait? Day 7 blastocysts have lower euploidy rates but similar sustained implantation rates as Day 5 and Day 6 blastocysts.
    Tiegs AW; Sun L; Patounakis G; Scott RT
    Hum Reprod; 2019 Sep; 34(9):1632-1639. PubMed ID: 31402381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IVF outcomes of embryos with abnormal PGT-A biopsy previously refused transfer: a prospective cohort study.
    Barad DH; Albertini DF; Molinari E; Gleicher N
    Hum Reprod; 2022 May; 37(6):1194-1206. PubMed ID: 35413106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimizing mosaicism: assessing the impact of fertilization method on rate of mosaicism after next-generation sequencing (NGS) preimplantation genetic testing for aneuploidy (PGT-A).
    Palmerola KL; Vitez SF; Amrane S; Fischer CP; Forman EJ
    J Assist Reprod Genet; 2019 Jan; 36(1):153-157. PubMed ID: 30362056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor oocyte recipients do not benefit from preimplantation genetic testing for aneuploidy to improve pregnancy outcomes.
    Doyle N; Gainty M; Eubanks A; Doyle J; Hayes H; Tucker M; Devine K; DeCherney A; Levy M; Jahandideh S; Hill M
    Hum Reprod; 2020 Nov; 35(11):2548-2555. PubMed ID: 33057600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Looking past the appearance: a comprehensive description of the clinical contribution of poor-quality blastocysts to increase live birth rates during cycles with aneuploidy testing.
    Cimadomo D; Soscia D; Vaiarelli A; Maggiulli R; Capalbo A; Ubaldi FM; Rienzi L
    Hum Reprod; 2019 Jul; 34(7):1206-1214. PubMed ID: 31247100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rationale for biopsying embryos reaching the morula stage on Day 6 in women undergoing preimplantation genetic testing for aneuploidy.
    Irani M; Zaninovic N; Canon C; O'Neill C; Gunnala V; Zhan Q; Palermo G; Reichman D; Rosenwaks Z
    Hum Reprod; 2018 May; 33(5):935-941. PubMed ID: 29546326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved clinical utility of preimplantation genetic testing through the integration of ploidy and common pathogenic microdeletions analyses.
    Caroselli S; Figliuzzi M; Picchetta L; Cogo F; Zambon P; Pergher I; Girardi L; Patassini C; Poli M; Bakalova D; Cimadomo D; Findikli N; Coban O; Serdarogullari M; Favero F; Bortolato S; Anastasi A; Capodanno F; Gallinelli A; Brancati F; Rienzi L; Ubaldi FM; Jimenez-Almazán J; Blesa-Jarque D; Miravet-Valenciano J; Rubio C; Simòn C; Capalbo A
    Hum Reprod; 2023 Apr; 38(4):762-775. PubMed ID: 36824049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.